Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001140361-23-013506 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-23	2023-03-21	TXG	Saxonov Serge	CEO, Dir	A - Grant	$0.00	+36.4K	899.8K	+4%	$0
DM	2023-03-23	2023-03-21	TXG	Saxonov Serge	CEO, Dir	A - Grant	$0.00	+145.5K	72.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-03-21	A	A	36,387	$0.00	899,792	D	—	—	(F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.
2	Derivative	Performance - based Restricted Stock Units	2023-03-21	A	A	72,773	$0.00	72,773	D	— · — to 2028-04-01	72,773 Class A Common Stock	(F7) Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.
3	Derivative	Stock Option (right to buy)	2023-03-21	A	A	72,773	$0.00	72,773	D	$50.10 · — to 2033-03-21	72,773 Class A Common Stock	(F6) 1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date.